Boston Scientific (BSX) Enterprise Value (2009 - 2026)

Boston Scientific has disclosed Enterprise Value across 18 years of filings, most recently posting -$1.2 billion for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$1.2 billion, down 146.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 146.54% YoY), and the FY2025 annual result was -$1.7 billion, down 362.73% from the prior year.
• Enterprise Value came in at -$1.2 billion for Q1 2026 at Boston Scientific, up from -$1.7 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$167.0 million in Q2 2023 to a low of -$2.7 billion in Q2 2024.
• The 5-year median for Enterprise Value is -$617.0 million (2023), against an average of -$931.1 million.
• Across the five-year window, Enterprise Value surged 89.68% in 2022 and plunged 1501.8% in 2024, its largest moves.
• Boston Scientific's Enterprise Value stood at -$928.0 million in 2022, then jumped by 33.51% to -$617.0 million in 2023, then soared by 39.55% to -$373.0 million in 2024, then plunged by 362.73% to -$1.7 billion in 2025, then increased by 29.72% to -$1.2 billion in 2026.
• The last three Enterprise Value figures came in at -$1.2 billion (Q1 2026), -$1.7 billion (Q4 2025), and -$1.0 billion (Q3 2025), per Business Quant data.